Nakagawa Kimie, Kawaura Akihiko, Kato Shigeaki, Takeda Eiji, Okano Toshio
Department of Hygienic Sciences, Kobe Pharmaceutical University, 4-19-1 Motoyamakita-machi, Higashinada-ku, Kobe 658-8558, Japan.
Carcinogenesis. 2005 Feb;26(2):429-40. doi: 10.1093/carcin/bgh332. Epub 2004 Nov 11.
1alpha,25-Dihydroxyvitamin D(3) [1alpha,25(OH)(2)D(3)], the major regulator of calcium homeostasis, has potent antiproliferative and anti-invasive properties in vitro in cancer cells. Studies in vivo demonstrated that 1alpha,25(OH)(2)D(3) slows the progression of breast, prostate and other carcinomas. A key question is whether 1alpha,25(OH)(2)D(3) exerts its anticarcinogenic effects in vivo by a mechanism that is dependent on its capacity to limit the proliferation and invasiveness of cancer cells in vitro. It has not been clear whether the calcemic activity and regulation of the host defenses by 1alpha,25(OH)(2)D(3) contribute to the effect on cancer cells. In this study we have focused on the influence of 1alpha,25(OH)(2)D(3) on the metastasis of lung cancer, without involvement of the calcemic activity and other effects of 1alpha,25(OH)(2)D(3) in the host. We used metastatic Lewis lung carcinoma cells expressing green fluorescent protein (LLC-GFP cells) and examined metastatic activity in vitamin D receptor (VDR) null mutant (VDR(-/-)) mice and their wild-type counterparts (VDR(+/+) mice). VDR(-/-) mice exhibit hypocalcemia and extremely high serum levels of 1alpha,25(OH)(2)D(3). We expected that serum 1alpha,25(OH)(2)D(3) would act in vivo to directly inhibit the metastatic growth of VDR-positive LLC-GFP cells in VDR(-/-) mice. The metastatic activities of LLC-GFP cells were remarkably reduced in VDR(-/-) mice compared with VDR(+/+) mice. To test the hypothesis that serum 1alpha,25(OH)(2)D(3) is an intrinsic factor that inhibits metastatic growth of lung cancer cells, we corrected hypocalcemia and/or hypervitaminosis D in VDR(-/-) mice by dietary manipulation. The metastatic growth of LLC-GFP cells was remarkably reduced in response to serum levels of 1alpha,25(OH)(2)D(3), but not to serum calcium levels. Furthermore, we found that VDR(+/+) mice fed the manipulated diets displayed an apparent inverse relationship between the physiological levels of serum 1alpha,25(OH)(2)D(3) (8-15 pg/ml) and tumorigenesis. Here we show that 1alpha,25(OH)(2)D(3) inhibits the metastatic growth of lung cancer cells in a defined animal model.
1α,25 - 二羟基维生素D(3)[1α,25(OH)₂D(3)]是钙稳态的主要调节因子,在体外对癌细胞具有强大的抗增殖和抗侵袭特性。体内研究表明,1α,25(OH)₂D(3)可减缓乳腺癌、前列腺癌和其他癌症的进展。一个关键问题是,1α,25(OH)₂D(3)在体内发挥抗癌作用的机制是否依赖于其在体外限制癌细胞增殖和侵袭的能力。目前尚不清楚1α,25(OH)₂D(3)的血钙活性和对宿主防御的调节是否对癌细胞产生影响。在本研究中,我们聚焦于1α,25(OH)₂D(3)对肺癌转移的影响,而不涉及1α,25(OH)₂D(3)在宿主中的血钙活性和其他作用。我们使用表达绿色荧光蛋白的转移性Lewis肺癌细胞(LLC - GFP细胞),并检测了维生素D受体(VDR)基因敲除突变小鼠(VDR⁻/⁻)及其野生型对照小鼠(VDR⁺/⁺)的转移活性。VDR⁻/⁻小鼠表现出低钙血症和极高的血清1α,25(OH)₂D(3)水平。我们预期血清1α,25(OH)₂D(3)在体内可直接抑制VDR⁻/⁻小鼠中VDR阳性LLC - GFP细胞的转移生长。与VDR⁺/⁺小鼠相比,LLC - GFP细胞在VDR⁻/⁻小鼠中的转移活性显著降低。为了验证血清1α,25(OH)₂D(3)是抑制肺癌细胞转移生长的内在因素这一假设,我们通过饮食调控纠正了VDR⁻/⁻小鼠的低钙血症和/或维生素D过多症。LLC - GFP细胞的转移生长对血清1α,25(OH)₂D(3)水平有显著降低反应,但对血清钙水平无反应。此外,我们发现喂食调控饮食的VDR⁺/⁺小鼠血清1α,25(OH)₂D(3)的生理水平(8 - 15 pg/ml)与肿瘤发生之间呈现明显的负相关关系。在此我们表明,在一个明确的动物模型中,1α,25(OH)₂D(3)可抑制肺癌细胞的转移生长。